Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deals and Financings

Set Alert for Deals

BD, CR Bard Merger To Create Vascular Access Device Giant

Becton Dickinson has reached a definitive agreement to acquire CR Bard for $24bn. BD says Bard's product portfolio gives it a strong presence in fast-growing clinical areas and more reach outside the US while Bard expects to reach more customers by building on BD's leadership in medication management and infection prevention.

Companies Commercial Deals
Advertisement

Latest From Deals

Device Week – April 21, 2017

On this week's Medtech Insight podcast we highlight two big M&A deals: Abbott & Alere, and Medtronic & Cardinal Health.

Commercial Deals

Cellnovo Targets 2018 Launch Of Insulin Micropump With Artificial Pancreas Tech

Cellnovo has signed a commercial license agreement with digital health firm TypeZero to integrate its artificial pancreas software technology into Cellnovo’s digitally connected insulin patch pump. The integrated product is expected to launch in 2018.

Deals Diabetic Care

DePuy Synthes Builds Out Trauma Offering With TRS' 3D-Printed Tech

Underlining its focus on 3D-printing and the potential this technology can bring, DePuy Synthes has acquired the 3D-printed scaffold platform of Tissue Regeneration Systems, enabling the orthopedics leader to develop patient-specific trauma products in-house.

Orthopedics M & A

Cardinal Health, Medtronic Tie Up $6.1bn Lower-Margin Assets Deal

Medtronic is selling certain lower-margin, lower growth assets within its Patient Monitoring and Recovery division to Cardinal Health in a $6.1bn deal. While the deal may benefit Medtronic's debt situation, the same cannot be said for the buyer.

M & A Deals

HiberGene Casts Net Wide For Series B Funding

From crowdfunding to taking on its distributor partner as investor, the varied fundraising routes that HiberGene traveled down for its series B round has enabled the Irish rapid molecular diagnostic test developer to raise €6.7m.

In Vitro Diagnostics Infectious Diseases

BioTelemetry Trumps Aevis' Takeover Bid For LifeWatch

Swiss firm LifeWatch has been offered a sweeter acquisition deal from BioTelemetry at a proposed CHF260m. The company was recently subject to a proposed takeover by investment firm Aevis Victoria SA.

Cardiology Deals

M&A Analysis: No Spring For March Mergers

M&A deal activity waned in March, with a total of 9 deals completed in the month, down from 12 in February and 17 in March 2016. This third month brought the total number of deals for Q1 2017 to 33, a significant year-on-year decline compared to 51 in the first quarter of 2016.

M & A Deals

Grünenthal Taps Into $1bn Surg Sealants Market With Adhesys

German pharma company Grünenthal is expanding its medical device portfolio with the acquisition of surgical adhesives specialist Adhesys Medical. The deal is expected to help Grünenthal achieve its five-year goal of hitting €2bn in sales by 2022.

M & A Wound Management

VC Deals Analysis: Big Boost From Bumper Round

It had been a slow start to the year but one unusually large financing round from cancer diagnostics company Grail means the first quarter of 2017 has now outpaced the performance from any in the previous four years.

StartUps and SMEs Financing
See All
UsernamePublicRestriction

Register